enGene Holdings Inc.
ENGN · NASDAQ
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $509 | $323 | $175 | $0 |
| Gross Profit | -$509 | -$323 | -$175 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $94,480 | $38,315 | $16,458 | $15,467 |
| G&A Expenses | $28,685 | $23,982 | $0 | $3,260 |
| SG&A Expenses | $28,685 | $23,982 | $9,427 | $3,260 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$323 | $0 | $700 |
| Operating Expenses | $123,165 | $61,974 | $25,885 | $19,427 |
| Operating Income | -$123,165 | $62,297 | -$26,060 | -$1,831 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5,863 | -$7,136 | -$73,840 | $1,862 |
| Pre-Tax Income | -$117,302 | $55,161 | -$99,900 | $31 |
| Tax Expense | $0 | -$19 | $17 | $0 |
| Net Income | $117,302 | -$55,142 | -$99,917 | $31 |
| % Margin | – | – | – | – |
| EPS | -2.29 | -1.46 | -4.24 | 0.002 |
| % Growth | -56.8% | 65.6% | -223,257.9% | – |
| EPS Diluted | -2.29 | -1.46 | -4.24 | 0.002 |
| Weighted Avg Shares Out | 51,119 | 44,638 | 23,557 | 15,813 |
| Weighted Avg Shares Out Dil | 51,119 | 44,638 | 23,557 | 15,813 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,426 | $10,413 | $1,117 | $129 |
| Interest Expense | $2,994 | $2,798 | $4,953 | $1,423 |
| Depreciation & Amortization | $509 | $323 | $175 | $238 |
| EBITDA | -$113,799 | -$52,040 | -$94,772 | $269 |
| % Margin | – | – | – | – |